נאופרו 4 מ"ג / 24 שעות
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
ROTIGOTINE 4 MG / 24 HOUR
Available from:
CTS LTD
ATC code:
N04BC09
Pharmaceutical form:
PATCHES
Administration route:
TRANSDERMAL
Manufactured by:
UCB MANUFACTURING IRELAND LTD
Therapeutic group:
ROTIGOTINE
Therapeutic indications:
Neupro is indicated for the treatment of the signs and symptoms of early-stage idiopathic Parkinson's disease as monotherapy (i.e. without levodopa) or in combination with levodopa, i.e. over the course of the disease, through the late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or "on-off" fluctuations).
Authorization date:
2012-09-01
